Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.370
-0.410 (-8.58%)
At close: Jun 5, 2026, 4:00 PM EDT
4.340
-0.030 (-0.69%)
After-hours: Jun 5, 2026, 7:26 PM EDT
Lexeo Therapeutics Employees
Lexeo Therapeutics had 59 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
59
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,483,068
Market Cap
343.14M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 59 | 0 | - |
| Dec 31, 2025 | 59 | -13 | -18.06% |
| Dec 31, 2024 | 72 | 14 | 24.14% |
| Dec 31, 2023 | 58 | 34 | 141.67% |
| Dec 31, 2021 | 24 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| REGENXBIO | 371 |
| Puma Biotechnology | 179 |
| Artiva Biotherapeutics | 104 |
| OmniAb | 89 |
| Century Therapeutics | 78 |
| Atea Pharmaceuticals | 55 |
| X4 Pharmaceuticals | 45 |
LXEO News
- 17 days ago - Lexeo Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 18 days ago - Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference - GlobeNewsWire
- 26 days ago - Lexeo Therapeutics reports Q1 EPS (25c), consensus (30c) - TheFly
- 26 days ago - Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights - GlobeNewsWire
- 26 days ago - Lexeo Therapeutics Quarterly report: Q1 2026 - Filings
- 26 days ago - Lexeo Therapeutics Earnings release: Q1 2026 - Filings
- 26 days ago - Lexeo Therapeutics Slides: Corporate presentation - Filings
- 5 weeks ago - Lexeo Therapeutics Proxy statement: Proxy filing - Filings